ATM loss confers greater sensitivity to ATR inhibition than PARP inhibition in prostate cancer

Shahrzad Rafiei, Kenyon Fitzpatrick, David Liu, Mu Yan Cai, Haitham A. Elmarakeby, Jihye Park, Cora Ricker, Bose S. Kochupurakkal, Atish D. Choudhury, William C. Hahn, Steven P. Balk, Justin H. Hwang, Eliezer M. van Allen, Kent W. Mouw

Research output: Contribution to journal › Article › peer-review